Vireo Growth (VREOF) Change in Cash (2020 - 2026)
Vireo Growth (VREOF) posted Change in Cash of $15.3 million for Q1 2026, up 208.74% sequentially from $5.0 million in Q4 2025, and up 383.33% YoY from $3.2 million in Q1 2025.
Vireo Growth (VREOF) Change in Cash (2020 - 2026) Analysis & Trends
Vireo Growth has reported Change in Cash for 7 years, with the latest figure at $15.3 million in Q1 2026.
- Quarterly Change in Cash rose 383.33% year-over-year to $15.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.6 million (down 29.91% YoY) and the FY2025 annual result came in at $30.9 million, down 59.16% from the prior year.
- Change in Cash advanced to $15.3 million in Q1 2026 per VREOF's latest filing, from $5.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $84.3 million in Q4 2024 and troughed at -$6.7 million in Q4 2022.
- A 5-year average of $7.2 million and a median of $2.0 million in 2023 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 3059.99% in 2024, down 302.53% in 2024.
- Over 5 years, Change in Cash stood at -$6.7 million in 2022, then jumped by 139.87% to $2.7 million in 2023, then jumped by 3059.99% to $84.3 million in 2024, then plunged by 94.12% to $5.0 million in 2025, then jumped by 208.74% to $15.3 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $15.3 million, $5.0 million, and $11.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn | -15.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.30 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | 11.35 Mn |
| Jun 30, 2025 | 19.98 Mn |
| Mar 31, 2025 | -5.40 Mn |
| Dec 31, 2024 | 84.33 Mn |
| Sep 30, 2024 | -3.95 Mn |
| Jun 30, 2024 | -1.37 Mn |
| Mar 31, 2024 | -3.36 Mn |
| Dec 31, 2023 | 2.67 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | -4.80 Mn |
| Dec 31, 2022 | -6.69 Mn |
| Sep 30, 2022 | 4.87 Mn |
| Jun 30, 2022 | 8.37 Mn |
| Mar 31, 2022 | -6.55 Mn |
| Dec 31, 2021 | 3.38 Mn |
| Sep 30, 2021 | -9.05 Mn |
| Jun 30, 2021 | -19.73 Mn |